Measure | IAP | DAP | NAP | Total | |
---|---|---|---|---|---|
(n = 143) | (n = 140) | (n = 139) | (n = 422) | ||
Age | mean (SD), years | 6.4 (3.1) | 6.4 (3.2) | 6.1 (2.8) | 6.3 (3.0) |
Girls | cases (%) | 75 (52.5) | 64 (45.7) | 77 (55.4) | 216 (51.2) |
Respiratory comorbidity | number (%) | 15 (10.5) | 14 (10.0) | 11 (7.9) | 40 (9.5) |
Respiratory infection | cases (%) | ||||
Rhinosinusitis | 8 (5.6) | 9 (6.4) | 8 (5.8) | 25 (5.9) | |
Pharyngitis | 46 (32.2) | 46 (32.9) | 49 (35.3) | 141 (33.4) | |
Acute bronchitis | 14 (9.8) | 12 (8.6) | 13 (9.4) | 39 (9.2) | |
Acute otitis media | 75 (52.5) | 73 (52.1) | 69 (49.6) | 217 (51.4) | |
Main specific symptomsa | mean (SD) | ||||
Severe (5–6) | days | 2.6 (5.4) | 2.4 (6) | 2.6 (6.5) | 3 (6) |
Moderate (3–4) | 6.9 (5.8) | 7 (6.3) | 6.9 (7.9) | 6.95(6.7) | |
Complicationsb | cases | 2 | 1 | 2 | 5 |
Antibioticsc | prescriptions used | 146 | 35 | 17 | 198 |
Non-antibiotic medicationc | prescriptions used | 173 | 200 | 231 | 604 |
Additional PC visitsc | visits, number | 16 | 15 | 18 | 49 |